Drug
Pacritinib
Pacritinib: highest development phase Phase 3, developed by Swedish Orphan Biovitrum. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Swedish Orphan Biovitrum
Trials
| Drug | Phase | Indication |
|---|---|---|
| Pacritinib NCT03165734 | Phase 3 | Primary Myelofibrosis |
| Pacritinib NCT07394153 | Phase 2 | Myelofibrosis，MF |
| Pacritinib NCT06782373 | Phase 2 | VEXAS |
Latest
No recent events.
Follow Pacritinib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.